Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in myocardial mnfarction - Cannon, CP; McCabe, CH; Borzak, S; Henry, TD; Tischler, MD; Mueller, HS; Feldman, R; Palmeri, ST; Ault, K; Hamilton, SA; Rothman, JM; Novotny, WF; Braunwald, E (Circulation, 1998)